ÂÜÀòÂÒÂ×

Aninda Katragadda has extensive experience in finance and leadership roles. Aninda is currently the Chief Financial Officer at Atavistik Bio since February 2022. Prior to that, they served as the SVP Finance at Akouos from August 2017 to January 2022. Aninda also worked as a Consultant at Surface Oncology Inc. from April 2017 to December 2019, and as the Head of Finance at Foghorn Therapeutics, Inc from April 2017 to February 2018. Additionally, Aninda held the position of Head of Finance at Voyager Therapeutics, Inc. from July 2015 to June 2017. Aninda'searlier roles include being the Senior Director External Reporting, Technical Accounting and Internal Controls at The Medicines Company from January 2011 to June 2015, and a CFO Consultant at Concert Pharmaceuticals from 2008 to 2011. Aninda has also worked at Metabolix as the Director of Finance, JV Operations from September 2008 to December 2009 and as the Principal Accounting Officer and Corp Controller from August 2005 to September 2008. Aninda started their career at Scion Pharmaceuticals as the VP Finance from 2001 to 2005, and they also served as the VP Finance at Digital Art Exchange from 1999 to 2001.

Aninda Katragadda holds a Bachelor of Science in Business Administration with a specialization in Accounting from the University of Missouri-Saint Louis. The duration of the degree program and any additional educational experiences are not provided.